Answers are grounded in this paper and cite their sources.
MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression that exhibit tissue- and condition-associated expression patterns. Interpreting their abundance in disease or experimental contexts requires a physiological reference. DIANA-miTED v2 expands its uniformly processed and manually curated collection from 15 183 to 49 630 human small RNA-sequencing profiles spanning healthy tissues, cell lines, and disease states. To our knowledge, this is the largest such collection of human miRNA expression profiles assembled to date. It adds 16 746 Genotype-Tissue Expression V10 profiles and expands the Sequence Read Archive collection from 4142 to 21 843, alongside the existing The Cancer Genome Atlas collection. Expression is quantified for 2656 mature miRNAs, with harmonized metadata covering 96 tissues or organs, 437 cell lines, and 503 diseases. Healthy-donor coverage increases from 709 to 23 281, with 1471 tumour-adjacent-normal profiles classified separately. The database distinguishes primary tissues and biofluids from cultured and derived preparations. A redesigned tissue-centric interface provides a body-map picker, sublocation refinement, multi-miRNA and multi-tissue querying, cohort summaries, and descriptive longitudinal browsing. Co-expression capabilities include pairwise Spearman correlation and precomputed WGCNA modules, with 263 overview and 105 source/project-specific reference networks. Quantified counts, reads per million values, metadata, and query results are available through downloads and a REST API. DIANA-miTED v2 is freely available, without registration, at http://microrna.gr/mitedv2.
No takes yet. Share an insight, caveat, or question.
Miliotis et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: